HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling Xu Selected Research

Stomach Neoplasms (Stomach Cancer)

7/2023Retracted: Upregulation of Serine Proteinase Inhibitor Clade B Member 3 (SERPINB3) Expression by Stromal Cell-Derived Factor (SDF-1)/CXCR4/Nuclear Factor kappa B (NF-κB) Promotes Migration and Invasion of Gastric Cancer Cells.
11/2021Decreased expression of ATF3, orchestrated by β-catenin/TCF3, miR-17-5p and HOXA11-AS, promoted gastric cancer progression via increased β-catenin and CEMIP.
1/2021NR2F1-AS1/miR-190a/PHLDB2 Induces the Epithelial-Mesenchymal Transformation Process in Gastric Cancer by Promoting Phosphorylation of AKT3.
11/2020Wnt/β-Catenin Signaling Axis Is Required for TFEB-Mediated Gastric Cancer Metastasis and Epithelial-Mesenchymal Transition.
10/2020Upregulation of Serine Proteinase Inhibitor Clade B Member 3 (SERPINB3) Expression by Stromal Cell-Derived Factor (SDF-1)/CXCR4/Nuclear Factor kappa B (NF-κB) Promotes Migration and Invasion of Gastric Cancer Cells.
4/2020β-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway.
1/2020PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR.
1/2020Fucoidan suppresses the gastric cancer cell malignant phenotype and production of TGF-β1 via CLEC-2.
7/2019Leucine-rich repeat neuronal protein-1 suppresses apoptosis of gastric cancer cells through regulation of Fas/FasL.
3/2019Role of abnormal microRNA expression in Helicobacter pylori associated gastric cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling Xu Research Topics

Disease

192Neoplasms (Cancer)
02/2024 - 09/2003
76Breast Neoplasms (Breast Cancer)
03/2024 - 03/2009
54Stomach Neoplasms (Stomach Cancer)
07/2023 - 02/2005
35Infections
01/2024 - 04/2005
33Neoplasm Metastasis (Metastasis)
07/2024 - 02/2005
30Lung Neoplasms (Lung Cancer)
02/2024 - 09/2003
29Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 11/2011
27Hepatocellular Carcinoma (Hepatoma)
01/2024 - 01/2012
25Leukemia
11/2023 - 07/2009
21Carcinogenesis
05/2023 - 12/2011
20Inflammation (Inflammations)
03/2024 - 03/2012
18Osteoporosis
05/2022 - 06/2003
17Dry Eye Syndromes (Dry Eye Syndrome)
02/2024 - 07/2020
16Carcinoma (Carcinomatosis)
01/2021 - 02/2005
13Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024 - 02/2011
12Pain (Aches)
01/2024 - 09/2007
11Wounds and Injuries (Trauma)
03/2024 - 01/2010
11Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2023 - 09/2009
11COVID-19
01/2023 - 05/2020
11Lymphoma (Lymphomas)
01/2022 - 03/2009
9Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2023 - 01/2015
8Necrosis
02/2024 - 11/2012
8Liver Neoplasms (Liver Cancer)
01/2024 - 12/2011
8Liver Cirrhosis (Hepatic Cirrhosis)
03/2023 - 01/2014
8Colorectal Neoplasms (Colorectal Cancer)
07/2021 - 09/2011
8Disease Progression
05/2021 - 11/2006
7Fatigue
02/2024 - 03/2012
7Fibrosis (Cirrhosis)
03/2023 - 01/2012
7Type 2 Diabetes Mellitus (MODY)
01/2023 - 10/2014
7Adenocarcinoma of Lung
10/2022 - 09/2003
7Atherosclerosis
12/2021 - 06/2016
6Ovarian Neoplasms (Ovarian Cancer)
07/2024 - 07/2012
6Pneumonia (Pneumonitis)
05/2024 - 04/2011
6Residual Neoplasm
12/2023 - 03/2009
6Hyperemia
12/2023 - 07/2020
6Hypoxia (Hypoxemia)
01/2021 - 03/2005
6Cancer Pain
07/2015 - 09/2007
5Alzheimer Disease (Alzheimer's Disease)
03/2024 - 01/2017
5Glioma (Gliomas)
10/2023 - 02/2014
5Body Weight (Weight, Body)
07/2023 - 01/2010
5Obesity
01/2023 - 01/2009
5Triple Negative Breast Neoplasms
12/2022 - 12/2014
5Human Influenza (Influenza)
11/2022 - 11/2005

Drug/Important Bio-Agent (IBA)

56Proteins (Proteins, Gene)FDA Link
03/2024 - 09/2003
39Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2013
24LipidsIBA
02/2024 - 05/2007
23LigandsIBA
01/2024 - 03/2009
22Messenger RNA (mRNA)IBA
01/2023 - 03/2005
21CytokinesIBA
02/2024 - 08/2004
21MicroRNAs (MicroRNA)IBA
08/2022 - 09/2009
18DNA (Deoxyribonucleic Acid)IBA
02/2024 - 09/2003
15RNA (Ribonucleic Acid)IBA
02/2024 - 09/2003
14ErbB Receptors (EGF Receptor)IBA
01/2024 - 01/2013
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 11/2006
12VaccinesIBA
01/2023 - 11/2002
11Antiviral Agents (Antivirals)IBA
12/2023 - 11/2016
11Transcription Factors (Transcription Factor)IBA
11/2023 - 01/2009
11Hormones (Hormone)IBA
06/2023 - 09/2010
10human ERBB2 proteinIBA
01/2024 - 12/2012
10AntibodiesIBA
01/2022 - 11/2005
9Therapeutic UsesIBA
02/2024 - 08/2004
9T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2023 - 04/2013
9Glucose (Dextrose)FDA LinkGeneric
01/2023 - 08/2012
9Insulin (Novolin)FDA Link
08/2022 - 05/2007
9Cisplatin (Platino)FDA LinkGeneric
01/2020 - 03/2009
8Epidermal Growth Factor (EGF)IBA
01/2024 - 11/2012
8Immune Checkpoint InhibitorsIBA
06/2023 - 01/2020
8Phenobarbital (Luminal)FDA Link
12/2022 - 02/2014
8Fluorouracil (Carac)FDA LinkGeneric
10/2016 - 05/2006
7CollagenIBA
03/2024 - 12/2011
7Immunoconjugates (Immunoconjugate)IBA
02/2024 - 09/2016
7Sorafenib (BAY 43-9006)FDA Link
01/2024 - 12/2017
7Trastuzumab (Herceptin)FDA Link
12/2023 - 12/2012
7Long Noncoding RNAIBA
06/2023 - 09/2014
7EnzymesIBA
03/2023 - 01/2013
7UbiquitinIBA
12/2022 - 07/2009
7AntigensIBA
11/2022 - 04/2011
7Indicators and Reagents (Reagents)IBA
01/2022 - 03/2011
6Ophthalmic Solutions (Eye Drops)IBA
12/2023 - 03/2022
6diquafosolIBA
12/2023 - 03/2022
6oxidized low density lipoproteinIBA
11/2023 - 06/2011
6Small Interfering RNA (siRNA)IBA
01/2023 - 01/2011
6Interleukin-6 (Interleukin 6)IBA
01/2023 - 01/2014
6AnthracyclinesIBA
12/2022 - 03/2009
6Carrier Proteins (Binding Protein)IBA
10/2022 - 09/2014
6Estrogens (Estrogen)FDA Link
08/2022 - 06/2009
6proanthocyanidinIBA
05/2019 - 05/2008
6Death Domain ReceptorsIBA
07/2014 - 03/2009
5Phosphotransferases (Kinase)IBA
01/2024 - 12/2011
5Fluorescein (Funduscein)FDA LinkGeneric
01/2023 - 05/2006
5Taxoids (Taxanes)IBA
12/2022 - 03/2009
5Estrogen ReceptorsIBA
12/2022 - 10/2013

Therapy/Procedure

96Therapeutics
07/2024 - 06/2006
46Drug Therapy (Chemotherapy)
07/2024 - 01/2008
26Neoadjuvant Therapy
03/2024 - 03/2009
24Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 09/2003
21Immunotherapy
01/2024 - 12/2008
8Adjuvant Chemotherapy
06/2023 - 03/2010
6Aftercare (After-Treatment)
01/2023 - 01/2013
5Radiotherapy
06/2023 - 11/2020